The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

SynopsisStomach cancer is the fifth most common cancer in the world The global Stomach Cancer and Gastric Cancer Treatment market was valued at US$ 3948 million in 2023 and is anticipated to reach US$ 9059.7 million by 2030, witnessing a CAGR of 12.6% during the.....

No Of Pages : 85
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisStomach cancer is the fifth most common cancer in the world The global Stomach Cancer and Gastric Cancer Drugs market was valued at US$ 3948 million in 2023 and is anticipated to reach US$ 9059.7 million by 2030, witnessing a CAGR of 12.6% during the for.....

No Of Pages : 83
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisColorectal cancer therapeutics market trends, there are a number of factors providing major impetus to the growth of these drugs. The global Colorectal Cancer Treatment market was valued at US$ 18610 million in 2023 and is anticipated to reach US$ 23800 .....

No Of Pages : 89
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisPreeclampsia, a rapidly progressive disorder is characterized by elevated blood pressure and excessive protein in the urine of pregnant women. The global Preeclampsia Diagnostic market was valued at US$ 500 million in 2023 and is anticipated to reach US$.....

No Of Pages : 75
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisExocrine pancreatic insufficiency refers to a medical condition which is characterized by the deficiency of the exocrine pancreatic enzymes. The global Exocrine Pancreatic Insufficiency Therapeutic market was valued at US$ 1567 million in 2023 and is ant.....

No Of Pages : 74
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisTreatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its .....

No Of Pages : 76
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisTreatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its .....

No Of Pages : 71
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisNeuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. The global Neuraminidase Inhibitors Drug market was valued at US$ 928 million in 2023 and is anticipated to reach US$ 1386.5 million by 2030, witnessin.....

No Of Pages : 72
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAnticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, d.....

No Of Pages : 78
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00